Nalu Medical
Nalu Medical develops battery-free, micro-implantable neurostimulation devices for chronic pain management. The company's flagship Nalu Neurostimulation System is FDA-cleared for peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS), featuring a minimally invasive implantable pulse generator powered wirelessly by an external therapy disc and controlled via smartphone app.
Acquired
Nalu Medical has been acquired
This company is no longer available on our private secondary market.
Overview
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2014
Employees
250–254
Total Funding
$85M
2 rounds
Funding
Total raised $85M across 2 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Last updated 06-25-2026
Latest Round
Type
Series E (extension)
Date
March 5, 2024
Amount
$20M
Valuation
—
Lead Investors
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| March 5, 2024 | Series E (extension) | $20M | — | B Capital |
| January 3, 2024 | Series E (initial) | $65M | — | Novo Holdings |
Prominent Investors
Leadership
Thomas West
President and Chief Executive Officer
Keegan Harper
Founder and Chairman
Lee Hartley
Founder and Chief Technology Officer
Daniel Pivonka
Co-Founder
Competitors
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Stimwave Technologies
Wireless micro-sized neurostimulation systems for minimally invasive peripheral nerve and spinal cord stimulation with external battery configuration
SPR Therapeutics
Peripheral nerve stimulation devices for chronic pain management
BlueWind Medical
Peripheral nerve stimulation technology for pain management
Mainstay Medical
Restorative neurostimulation technology for chronic pain
Neuspera Medical
Peripheral nerve stimulation devices for chronic pain treatment
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.